Evidence map›Paper›PMID 33962619›Full record

Observational studyCardiovascular diabetology2021

Sex differences in the association of prediabetes and type 2 diabetes with microvascular complications and function: The Maastricht Study.

Rianneke de Ritter, Simone J S Sep, Carla J H van der Kallen, Marleen M J van Greevenbroek, Marit de Jong, Rimke C Vos, Michiel L Bots, Jos P H Reulen, Alfons J H M Houben, Carroll A B Webers and 7 more

Open access · goldAbstract readComparative StudyObservational Study
In one paragraph

Observational study in Cardiovascular diabetology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Rianneke de RitterDepartment of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands. rianneke.de.ritter@mumc.nl.ORCID 0000-0003-2858-1874
Simone J S SepDepartment of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Carla J H van der KallenDepartment of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Marleen M J van GreevenbroekDepartment of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Marit de JongJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Rimke C VosJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Michiel L BotsJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Jos P H ReulenDepartment of Clinical Neurophysiology, Maastricht University Medical Center+, Maastricht, The Netherlands.
Alfons J H M HoubenDepartment of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Carroll A B WebersDepartment of Ophthalmology, Maastricht University Medical Center+, Maastricht, The Netherlands.
Tos T J M BerendschotDepartment of Ophthalmology, Maastricht University Medical Center+, Maastricht, The Netherlands.
Pieter C DagnelieDepartment of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Simone J P M EussenCARIM Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
Miranda T SchramDepartment of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Annemarie KosterDepartment of Social Medicine, Maastricht University, Maastricht, The Netherlands.
Sanne A E PetersJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Coen D A StehouwerDepartment of Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Maastricht University Medical Centre · NLMaastricht University · NLUtrecht University · NLThe George Institute for Global Health · GB

Funding

British Heart Foundation PG/16/57/32256Medical Research Council MR/P014550/1Medical Research Council MR/P014550/2
6 · The paper itself

Abstract

backgroundWomen with type 2 diabetes are disproportionally affected by macrovascular complications; we here investigated whether this is also the case for microvascular complications and retinal microvascular measures.

methodsIn a population-based cohort study of individuals aged 40-75 years (n = 3410; 49% women, 29% type 2 diabetes (oversampled by design)), we estimated sex-specific associations, and differences therein, of (pre)diabetes (reference: normal glucose metabolism), and of continuous measures of glycemia with microvascular complications and retinal measures (nephropathy, sensory neuropathy, and retinal arteriolar and venular diameters and dilatation). Sex differences were analyzed using regression models with interaction terms (i.e. sex-by- (pre)diabetes and sex-by-glycemia) and were adjusted for potential confounders.

resultsMen with type 2 diabetes (but not those with prediabetes) compared to men with normal glucose metabolism, (and men with higher levels of glycemia), had significantly higher prevalences of nephropathy (odds ratio: 1.58 95% CI (1.01;2.46)) and sensory neuropathy (odds ratio: 2.46 (1.67;3.63)), larger retinal arteriolar diameters (difference: 4.29 µm (1.22;7.36)) and less retinal arteriolar dilatation (difference: - 0.74% (- 1.22; - 0.25)). In women, these associations were numerically in the same direction, but generally not statistically significant (odds ratios: 1.71 (0.90;3.25) and 1.22 (0.75;1.98); differences: 0.29 µm (- 3.50;4.07) and: - 0.52% (- 1.11;0.08), respectively). Interaction analyses revealed no consistent pattern of sex differences in the associations of either prediabetes or type 2 diabetes or glycemia with microvascular complications or retinal measures. The prevalence of advanced-stage complications was too low for evaluation.

conclusionsOur findings show that women with type 2 diabetes are not disproportionately affected by early microvascular complications.

Indexed as

Health Status DisparitiesAdultAgedBiomarkersBlood GlucoseCross-Sectional StudiesDiabetes Mellitus, Type 2Diabetic AngiopathiesDiabetic NephropathiesDiabetic NeuropathiesDiabetic RetinopathyFemaleHumansMaleMicrocirculationMiddle AgedBiomarkersBlood GlucoseEpidemiologyMicrovascular complicationsNephropathyNeuropathyRetinopathySexSex differenceType 2 diabetesWomen

Identifiers

PMID33962619
PMCPMC8106227
OpenAlexW3159482848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.